ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,282.40
1.44%
Dow Jones
40,421.36
0.33%
Brent Oil
81.565
-0.87%
Bitcoin
67,939.49
-0.32%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) News

FEMY

Femasys (FEMY)

Femasys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateTimeSourceHeadlineSymbolCompany
07/15/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
07/15/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
07/15/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
07/15/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
07/12/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/27/20248:30AMGlobeNewswire Inc.Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in AmsterdamNASDAQ:FEMYFemasys Inc
06/20/20248:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
06/20/20248:30AMGlobeNewswire Inc.Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in EuropeNASDAQ:FEMYFemasys Inc
06/07/20244:01PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FEMYFemasys Inc
05/17/20248:30AMGlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeNASDAQ:FEMYFemasys Inc
05/16/20248:30AMGlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy CouncilNASDAQ:FEMYFemasys Inc
05/09/20248:40AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
05/09/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
05/09/20248:30AMGlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
05/07/20248:30AMGlobeNewswire Inc.Femasys Expands Commercial Management Team with Addition of Experienced New HiresNASDAQ:FEMYFemasys Inc
04/18/20248:30AMGlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
03/28/20244:05PMGlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
03/21/20249:00AMGlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
03/20/20248:15AMGlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
03/13/20249:00AMGlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
03/06/20249:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/06/20249:00AMGlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
02/28/20249:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/13/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/13/20249:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/06/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
02/02/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
02/02/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
12/11/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Your Recent History

BIT
NSCIT0556695
Generalfinance
BITMOT
937768
Generali Green Bond 5,8%...
BITMOT
719552
Ggb Fb25 Sc Eur
TG
V60D
Vanguard LifeStrategy 60...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved